Despite their efficacy in promoting weight loss, GLP-1 drugs like Ozempic have brought with them some unintended consequences, particularly concerning gut health
10.1152/ad-van.00025.2003 161 WilliamsD
Lipton, MD, Professor of Neurology and Director of the Montefiore Headache Center, Albert Einstein College of Medicine, commented, A significant proportion of migraine patients experience inadequate efficacy with currently available acute treatments, leading to even greater suffering, and an increased risk of worsening of migraine pain and attack frequency
particularly low-volume rural and small hospitals may be unable to report on many of the included measures
AstraZeneca's agreement with CSPC Pharmaceutical Group goes beyond the headline figure
Schedule a consultation with The Johnson Center for Health today and start your journey to better healthone gut bug at a time